Please login to the form below

Not currently logged in
Email:
Password:

US pharma

This page shows the latest US pharma news and features for those working in and with pharma, biotech and healthcare.

US politicians round on generics firms for blocking drug pricing probe

US politicians round on generics firms for blocking drug pricing probe

Renews focus on increases in generic drug prices. US politicians are going after Heritage Pharmaceuticals, Mylan and Teva Pharmaceutical Industries for allegedly stonewalling an earlier effort to gather drug pricing information.

Latest news

  • Novartis chooses internal replacement for US pharma president role Novartis chooses internal replacement for US pharma president role

    Victor Bulto to lead US pharma business. Novartis has announced that Fabrice Chouraqui will be replaced by Victor Bulto (pictured above) as the company’s new president of its US pharmaceuticals ... Bulto is currently the head of Novartis’ US

  • GSK hires Merck KGaA exec to lead US pharma business GSK hires Merck KGaA exec to lead US pharma business

    Martinez-Davis will play a role in trying to make a success of those launches, leveraging both her experience of oncology drugs and the US market. ... Bailey joined GSK in 2009 and replaced Deirdre Connelly as president of the US pharmaceuticals unit in

  • Novo Nordisk boosted by new type 2 diabetes launches Novo Nordisk boosted by new type 2 diabetes launches

    According to Novo Nordisk, the sales decline of insulin was driven by declining sales and increased competition pressure in the US. ... However, the Danish pharma company also reported that its GLP-1 sales increased by 14% in North America, with a strong

  • Basilea moves closer to US filing of novel antibiotic Basilea moves closer to US filing of novel antibiotic

    Ceftobiprole is already marketed as  Zevtera and Mabelio for hospital and community-acquired pneumonia (HAP and CAP) in Europe and other ex-US markets through multiple partner companies. ... the high incidence of MRSA in US hospitals and the higher

  • Who's calling the shots in European healthcare? Who's calling the shots in European healthcare?

    Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis. ... PME: A number of stakeholders say that EFPIA’s opposition to the SPC Waiver was disproportionate, and influenced by US pharma lobby groups such as PhRMA.

More from news
Approximately 7 fully matching, plus 717 partially matching documents found.

Latest Intelligence

  • The Orkambi blame game The Orkambi blame game

    The three-hour evidence session also bore some resemblance to the recent interrogation of seven big pharma CEOs by a US Senate committee enquiry into US drug prices, albeit with just ... NHS England accusing Vertex of being an“extreme outlier” and

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    For the US market, this would formerly have been seen as an outrageous idea, and US pharma CEOs and industry lobby group PhRMA have opposed the move. ... These battles over pricing and access in the US market remain among the biggest priorities for

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    So how long before China eclipses the European market as the second most important behind the US? ... AstraZeneca is just one of several multinational pharma companies working with China’s homegrown tech companies.

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    to encourage a home-grown pharma industry, as well as investment from multinational giant. ... Big pharma reaps the benefits. There is no question that established US and European big pharma companies are also reaping the benefits of the new China boom.

  • Six degrees of participation Six degrees of participation

    The era of Participatory Medicine - aka collaborative care or shared decision-making - is upon us, and fittingly for pharma, it’s the taking part that counts. ... UK, as well as the Head of Digital and therapeutic heads from within the pharma client

More from intelligence
Approximately 0 fully matching, plus 46 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 60 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics